Petrolite Corp. v. Baker Hughes Inc.

Decision Date27 September 1996
Docket NumberNo. 95-1447,95-1447
Citation40 USPQ2d 1201,96 F.3d 1423
PartiesPETROLITE CORPORATION, Plaintiff-Appellant, v. BAKER HUGHES INCORPORATED and Baker Performance Chemicals Incorporated, Defendants-Appellees.
CourtU.S. Court of Appeals — Federal Circuit

James H. Riley, II, Pravel, Hewitt, Kimball & Krieger, Houston, TX, argued, for plaintiff-appellant.

David G. Mangum, Parsons, Behle & Latimer, Salt Lake City, UT, argued, for defendants-appellees. With him on the brief was C. Kevin Speirs.

Before MAYER, MICHEL, and BRYSON, Circuit Judges.

MAYER, Circuit Judge.

Petrolite Corporation appeals the judgment of the United States District Court for the Western District of Oklahoma, holding on summary judgment that United States Patent No. 4,978,512, is invalid under 35 U.S.C. § 102(b). Petrolite Corp. v. Baker Hughes Inc., Civ. Action No. Civ-94-311 (W.D.Ok. Mar. 20, 1995) (final judgment order). Because we agree with the district court that Petrolite has not raised a genuine issue as to any material fact and that Baker Hughes Inc. and its subsidiary Baker Performance Chemicals Inc. (Baker) are entitled to judgment as a matter of law, we affirm.

Background

In mid-1987, Quaker Petroleum Chemicals Co. began experimenting with methods for reducing the amount of hydrogen sulfide, a corrosive and toxic gas, in hydrocarbon streams such as oil or natural gas. The chemicals used in this process are called "hydrogen sulfide scavengers." In November 1987, after experiencing difficulties with various methods in cold weather, a Quaker employee developed the method claimed in the '512 patent, in which formaldehyde and monoethanolamine ("MEA") are mixed to form a reaction product used as a hydrogen sulfide scavenger. Quaker applied for the patent on December 23, 1988. Petrolite purchased the rights to the '512 patent from Quaker in 1993, following its reexamination.

Petrolite sued Baker for patent infringement on March 4, 1994. Baker moved for summary judgment of invalidity, arguing that Quaker had publicly used or sold the claimed invention non-experimentally more than one year before the date it filed for the patent. The district court granted Baker's motion, and Petrolite appeals.

Discussion

The issue is whether the district court erred in granting Baker's motion for summary judgment of invalidity. We review a district court's grant of summary judgment de novo. Meyers v. Asics Corp., 974 F.2d 1304, 1306, 24 USPQ2d 1036, 1037 (Fed.Cir.1992). Summary judgment is appropriate when there is no genuine issue as to any material fact and the moving party is entitled to judgment as a matter of law. Transmatic, Inc. v. Gulton Indus., Inc., 53 F.3d 1270, 1274, 35 USPQ2d 1035, 1038 (Fed.Cir.1995).

Under 35 U.S.C. § 102, a patent is invalid if "the invention was ... in public use or on sale in this country, more than one year prior to the date of the application for patent in the United States." 35 U.S.C. § 102(b) (1994). Quaker filed for its patent on December 23, 1988. Thus, the critical date for the public use and on sale inquiry is December 23, 1987. If Quaker used its invention in public, sold it, or offered it for sale within the meaning of the statute before that date, its patent is invalid. Public use includes "any use of [the claimed] invention by a person other than the inventor who is under no limitation, restriction or obligation of secrecy to the inventor." In re Smith, 714 F.2d 1127, 1134, 218 USPQ 976, 983 (Fed.Cir.1983).

Whether a public use has occurred is a question of law, Barmag Barmer Maschinenfabrik AG v. Murata Mach. Ltd., 731 F.2d 831, 836-37, 221 USPQ 561, 565-66 (Fed.Cir.1984), and "[t]his court has emphasized that the totality of the circumstances must be considered in determining whether a particular event creates an on-sale or public use bar." U.S. Environmental Prods. Inc. v. Westall, 911 F.2d 713, 716, 15 USPQ2d 1898, 1901 (Fed.Cir.1990); see also Tone Bros., Inc. v. Sysco Corp., 28 F.3d 1192, 1198, 31 USPQ2d 1321, 1324 (Fed.Cir.1994); TP Labs., Inc. v. Professional Positioners, Inc., 724 F.2d 965, 971, 220 USPQ 577, 582 (Fed.Cir.1984). The policies underlying the bar, such as "allowing the inventor a reasonable amount of time ... to determine the potential economic value of a patent" and "prohibiting the inventor from commercially exploiting the invention for a period greater than the statutorily prescribed time," are also relevant to the public use determination. Tone Bros., 28 F.3d at 1198, 31 USPQ2d at 1324-25. On summary judgment, once an alleged infringer presents facts sufficient to establish a prima facie case of public use, it falls to the patent owner to come forward with some evidence raising a genuine issue of material fact to the contrary. Sinskey v. Pharmacia Ophthalmics, Inc., 982 F.2d 494, 498, 25 USPQ2d 1290, 1293 (Fed.Cir.1992); U.S. Environmental Prods., 911 F.2d at 716, 15 USPQ2d at 1901; Harrington Mfg. Co. v. Powell Mfg. Co., 815 F.2d 1478, 1482, 2 USPQ2d 1364, 1367 (Fed.Cir.1986).

Petrolite's central argument is that the district court abused its discretion by enforcing its local rules and deeming Baker's statement of facts admitted because Petrolite failed to contest them. The rule provides that "[a]ll material facts set forth in the statement of the movant shall be deemed admitted for the purpose of summary judgment unless specifically controverted by the statement of the opposing party." Local Rule 14(b). * To avoid having the movant's facts deemed admitted, the rule provides that the brief in opposition must "begin with a section that contains a concise statement of material facts as to which the party contends a genuine issue exists." The rule also requires that "[e]ach fact in dispute ... be numbered and ... refer with particularity to those portions of the record upon which the opposing party relies, and, if applicable, ... state the number of the movant's fact that is disputed." Id.

Under Rule 83 of the Federal Rules of Civil Procedure, "[e]ach district court, acting by a majority of judges, may, after giving appropriate notice and an opportunity for comment, make and amend rules governing its practice.... A local rule takes effect on the date specified by the district court and remains in effect unless amended by the court or abrogated by the judicial council of the circuit." Fed.R.Civ.P. 83(a)(1) (1995). Local rules have the force of law, Weil v. Neary, 278 U.S. 160, 169, 49 S.Ct. 144, 148, 73 L.Ed. 243 (1929), and "a district court's construction of its own rule" will be reversed only if "the appellate court is convinced that the district court has misconstrued its own rule." 12 Charles A. Wright & Arthur R. Miller, Federal Practice & Procedure § 3153 (1973) (citing, for example, Woodham v. American Cystoscope Co., 335 F.2d 551 (5th Cir.1964)). Petrolite did not comply with the rule, and the district court's actions in enforcing it were proper.

Petrolite also argues that the court erred in invalidating all of the claims, because only four claims were at issue. However, the pleadings and other court documents show that Baker argued that all of the claims were invalid. For example, in Baker's answer to Petrolite's complaint, Baker alleges that "U.S. patent 4,978,512 is invalid and unenforceable because of failure to comply with one or more of the provisions of Title 35, United States Code, including 35 U.S.C. §§ 102, 103, and 112." The final pretrial order, which both parties approved, states that "Baker contends that Petrolite is entitled to nothing because ... every claim of the '512 patent is invalid...." Thus, Petrolite cannot now contend that these claims were not in dispute.

When analyzed in light of the facts that the district court properly deemed admitted, Petrolite's substantive arguments are without merit. It does not contest that the W-3053 chemical was publicly used and sold prior to the critical date. Rather, it argues only that these pre-critical date uses and sales were experimental "because the chemical was not known to work for its intended purpose and ... the transaction[s] took place as part of a program of experimentation to determine if the chemical would work for that purpose."

"The use of an invention by the inventor himself, or of any other person under his direction, by way of experiment, and in order to bring the invention to perfection, has never been regarded as [a public] use." City of Elizabeth v. American Nicholson Pavement Co., 97 U.S. 126, 134, 24 L.Ed. 1000 (1877); TP Labs., 724 F.2d at 971, 220 USPQ at 582. "The burden was on [Petrolite] to present some evidence that would raise a genuine issue of material fact over [the] allegation of experimental use." Sinskey, 982 F.2d at 497, 25 USPQ2d at 1293. "To establish that an otherwise public use or sale does not run afoul of section 102(b), it must be shown that the activity was 'substantially for purposes of experiment.' " Id. at 498, 982 F.2d 494, 25 USPQ2d at 1294 (quoting Baker Oil Tools, Inc. v. Geo Vann, Inc., 828 F.2d 1558, 1564, 4 USPQ2d 1210, 1214 (Fed.Cir.1987)). Thus, Petrolite had to present admissible evidence raising a genuine issue of material fact that "the primary purpose of the work was experimental." Baker Oil Tools, 828 F.2d at 1563, 4 USPQ2d at 1213.

Experimental use is a question of law to be analyzed based on the totality of the surrounding circumstances. Tone Bros., 28 F.3d at 1198, 31 USPQ2d at 1324. "Objective evidence such as the length of the test period, whether payment was made for the device, whether there was a secrecy agreement, whether progress reports were kept, whether someone other than the inventor conducted the experiments, and the overall number of tests may be considered." Sinskey, 982 F.2d at 498, 25 USPQ2d at 1294; In re Brigance, 792 F.2d 1103, 1108, 229 USPQ 988, 991 (Fed.Cir.1986); TP Labs., 724 F.2d at 971-72, 220 USPQ at 582. Here, the district...

To continue reading

Request your trial
49 cases
  • Evans Medical Ltd. v. American Cyanamid Co.
    • United States
    • U.S. District Court — Southern District of New York
    • 10 Junio 1998
    ...the vaccine in the United States would respond differently to it than children inoculated in Japan. Compare Petrolite Corp. v. Baker Hughes Inc., 96 F.3d 1423, 1427 (Fed. Cir.1996) (patent invalid under § 102(b) where inventor had successfully tested product, even though additional tests we......
  • Lough v. Brunswick Corp.
    • United States
    • U.S. Court of Appeals — Federal Circuit
    • 2 Enero 1997
    ...Walker on Patents § 7:28.5 Subsequent cases have followed in this distortion of binding precedent. See, e.g., Petrolite Corp. v. Baker Hughes Inc., 96 F.3d 1423, 1425, 40 USPQ.2d 1201, 1203 (Fed.Cir.1996) (citing Barmag, 731 F.2d at 836-37); Baxter Int'l, Inc. v. COBE Lab., Inc., 88 F.3d 10......
  • C.R. Bard, Inc. v. M3 Systems, Inc.
    • United States
    • U.S. Court of Appeals — Federal Circuit
    • 30 Septiembre 1998
    ...Marine Elecs., Inc. v. Furuno Elec. Co., 764 F.2d 840, 844, 226 USPQ 334, 337 (Fed.Cir.1985); see Petrolite Corp. v. Baker Hughes, Inc., 96 F.3d 1423, 1425, 40 USPQ2d 1201, 1203 (Fed.Cir.1996) ("This court has emphasized that the totality of the circumstances must be considered in determini......
  • Smithkline Beecham Corp. v. Apotex Corp.
    • United States
    • U.S. District Court — Northern District of Illinois
    • 3 Diciembre 2001
    ...process. See, e.g., Baxter International, Inc. v. COBE Labs., Inc., 88 F.3d 1054, 1060 (Fed.Cir.1996); Petrolite Corp. v. Baker Hughes, Inc., 96 F.3d 1423, 1427-28 (Fed.Cir.1996). For example in In re Hamilton, cited by TorPharm, the Federal Circuit commented, "What is remarkable about the ......
  • Request a trial to view additional results
4 books & journal articles
  • Appeals to the Court of Appeals for the Federal Circuit
    • United States
    • ABA Archive Editions Library ANDA litigation: strategies and tactics for pharmaceutical patent litigators. Second edition
    • 23 Junio 2016
    ...review de novo”). 33. While a grant of summary judgment is reviewed de novo by the Federal Circuit, Petrolite Corp. v. Baker Hughes Inc., 96 F.3d 1423, 1425 (Fed. Cir. 1996) (“We review a district court’s grant of summary judgment de novo.”); Glaverbel Societé Anonymé & Fosbel, Inc. v. Nort......
  • Appeals to the Court of Appeals for the Federal Circuit
    • United States
    • ABA Archive Editions Library ANDA litigation: strategies and tactics for pharmaceutical patent litigators. First edition
    • 22 Junio 2012
    ...denial of summary judgment unless we find that the court has indeed abused its discretion.”’); Petrolite Corp. v. Baker Hughes Inc., 96 F.3d 1423, 1425 (Fed. Cir. 1996) (“We review a district court’s grant of summary judgment de novo.”); Glaverbel Societé Anonymé & Fosbel, Inc. v. Northlake......
  • CHAPTER 3 THE LINOWES COMMISSION - WHERE ARE WE 25 YEARS LATER?
    • United States
    • FNREL - Special Institute Federal and Indian Oil and Gas Royalty Valuation and Management (FNREL) 2007
    • Invalid date
    ...H.R. 1975. [93] See Alberta Department of Energy, Alberta Oil and Gas Tenure 2005. [94] See, e.g., Petrolite Corp. v. Baker Hughes Inc., 96 F.3d 1423, 1425 (Fed. Cir. 1996). This is a patent infringement case involving U.S. Patent 4,978,512 entitled Composition and Method for Sweetening Hyd......
  • Does the Experimental Use Exception in Patent Law Have a Future?
    • United States
    • Colorado Bar Association Colorado Lawyer No. 47-1, January 2018
    • Invalid date
    ...Co. . . . which is the starting place for analysis of any case involving experimental use.”). [47] Petrolite Corp. v. Baker Hughes Inc., 96 F.3d 1423, 1426 (Fed. Cir. 1996) (“Experimental use is a question of law to be analyzed based on the totality of the surrounding circumstances.”); Loug......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT